Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of neurotrauma"
DOI: 10.1089/neu.2015.4313
Abstract: A Phase III, double-blind, placebo-controlled trial (ProTECT III) found that administration of progesterone did not reduce mortality or improve functional outcome as measured by the Glasgow Outcome Scale Extended (GOSE) in subjects with moderate to… read more here.
Keywords: severe traumatic; subjects moderate; administration progesterone; injury ... See more keywords
THU0117 PHARMACOKINETICS AND SHORT-TERM SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.2325
Abstract: Background Filgotinib (FIL) is an oral selective Janus kinase 1 (JAK1) inhibitor being developed to treat inflammatory diseases. Objectives This phase 1 study evaluated the pharmacokinetics (PK) and short-term safety of FIL in subjects with… read more here.
Keywords: gilead sciences; sciences inc; employee gilead; subjects moderate ... See more keywords
Resistance Training Improves Sleep Quality in Subjects With Moderate Parkinson's Disease
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Strength and Conditioning Research"
DOI: 10.1519/jsc.0000000000001685
Abstract: Abstract Silva-Batista, C, de Brito, LC, Corcos, DM, Roschel, H, de Mello, MT, Piemonte, MEP, Tricoli, V, and Ugrinowitsch, C. Resistance training improves sleep quality in subjects with moderate Parkinson's disease. J Strength Cond Res… read more here.
Keywords: quality; improves sleep; subjects moderate; training improves ... See more keywords